Panagora Asset Management’s Cocrystal Pharma COCP Stock Holding History

Panagora Asset Management’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-87	Closed	-$1K	–	2575
2020 Q1	$1K	Hold	87	–	–	﹤0.01%	2433
2019 Q4	$1K	Buy	87 +30	+53%	+$300	﹤0.01%	2394
2019 Q3	$1K	Sell	57 -381	-87%	-$9.87K	﹤0.01%	2405
2019 Q2	$12K	Sell	438 -375	-46%	-$11.1K	﹤0.01%	2369
2019 Q1	$27K	Sell	813 -396	-33%	-$14.5K	﹤0.01%	2192
2018 Q4	$52K	Buy	1,209 +364	+43%	+$12K	﹤0.01%	1956
2018 Q3	$25K	Buy	845 +550	+186%	+$24.6K	﹤0.01%	2175
2018 Q2	$13K	Buy	+295	New	+$10.9K	﹤0.01%	2237

Other funds holding COCP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Panagora Asset Management's COCP Position: Q2 2020 in Review

Panagora Asset Management sold out of Cocrystal Pharma (COCP) in Q2 2020, closing a stake of 87 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in COCP in Q2 2018 and held it in 8 quarters. The position peaked at $52K in Q4 2018. 21 funds tracked by Wall St. Rank hold COCP as of Q2 2020.

Panagora Asset Management reported no remaining Cocrystal Pharma position as of Q2 2020 after selling out during the quarter.
Panagora Asset Management sold 87 Cocrystal Pharma shares in Q2 2020, an estimated $1K.
Panagora Asset Management first reported a position in Cocrystal Pharma in Q2 2018 and held it in 8 quarters.
Panagora Asset Management's Cocrystal Pharma position peaked at $52K in Q4 2018.
21 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2020.

Based on Panagora Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.